Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study ; volume:20 ; number:1 ; day:6 ; month:12 ; year:2022 ; pages:1-12 ; date:12.2022
Journal of translational medicine ; 20, Heft 1 (6.12.2022), 1-12, 12.2022
- Urheber
-
Hooshmand, Kosar
Goldstein, David
Timmins, Hannah C.
Li, Tiffany
Harrison, Michelle
Friedlander, Michael L.
Lewis, Craig R.
Lees, Justin G.
Moalem-Taylor, Gila
Guennewig, Boris
Park, Susanna B.
Kwok, John B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-022-03754-4
- URN
-
urn:nbn:de:101:1-2023021621163439240963
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hooshmand, Kosar
- Goldstein, David
- Timmins, Hannah C.
- Li, Tiffany
- Harrison, Michelle
- Friedlander, Michael L.
- Lewis, Craig R.
- Lees, Justin G.
- Moalem-Taylor, Gila
- Guennewig, Boris
- Park, Susanna B.
- Kwok, John B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions
Diagnosis of peripheral neuropathy
Painful Peripheral Neuropathy and Cancer
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action
Exploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions
Diagnosis of peripheral neuropathy
Painful Peripheral Neuropathy and Cancer
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action
Exploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions
Diagnosis of peripheral neuropathy
Painful Peripheral Neuropathy and Cancer
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action